Suppr超能文献

评估透析患者液体状态变化方法的检测限

Detection limit of methods to assess fluid status changes in dialysis patients.

作者信息

Kraemer M, Rode C, Wizemann V

机构信息

Fresenius Biotech GmbH, Bad Homburg, Germany.

出版信息

Kidney Int. 2006 May;69(9):1609-20. doi: 10.1038/sj.ki.5000286.

Abstract

Technical systems for an accurate and practicable fluid management of dialysis patients are urgently needed, since current clinical methods are partially subjective, imprecise, and time consuming. Such new systems should not only allow the determination of the target normohydration weight, but also must be able to detect clinically relevant changes in fluid volume ( approximately 1 l). This study focuses on the systematic analysis of the detection limit of several candidate methods for fluid management. In a cohort of 16 new dialysis patients, several candidate methods were applied in parallel during each treatment of the initial weight reduction phase: the measurement of vena cava diameter (VCD), vena cava collapsibility index (CI), the blood volume drop during an ultrafiltration (UF) bolus (Deltarelative blood volume (RBV)-), the rebound after the UF bolus (DeltaRBV+), and the extracellular fluid volume determined with whole body bioimpedance spectroscopy (BIS). A clinical reference method was used to manage the fluid status of patients. All methods showed significant correlations with predialysis weight. The detection limits W(lim) of candidate methods for changes in fluid status were assessed as W(lim)=0.87 kg+/-0.64 kg (BIS), 1.74 kg+/-1.56 kg (VCD), 2.3 kg+/-1.0 kg (DeltaRBV-), 7.4 kg+/-8.5 kg (CI), 40 kg+/-108 kg (DeltaRBV+). Only BIS shows a satisfactorily low detection limit W(lim), whereas W(lim) was rated as critical for the VCD and DeltaRBV- methods, and as unacceptable for the CI and DeltaRBV+ methods. Bioimpedance spectroscopy appears to be the most promising method for a practical fluid management system in dialysis.

摘要

由于目前的临床方法部分具有主观性、不精确且耗时,因此迫切需要用于透析患者精确且实用的液体管理的技术系统。这样的新系统不仅应能确定目标正常水化体重,还必须能够检测临床上相关的液体量变化(约1升)。本研究着重于对几种液体管理候选方法的检测限进行系统分析。在16名新透析患者的队列中,在初始体重减轻阶段的每次治疗期间并行应用了几种候选方法:腔静脉直径(VCD)测量、腔静脉塌陷指数(CI)、超滤(UF)推注期间的血容量下降(相对血容量(RBV)变化量 -)、UF推注后的反弹(ΔRBV +)以及用全身生物电阻抗光谱法(BIS)测定的细胞外液量。使用一种临床参考方法来管理患者的液体状态。所有方法均与透析前体重显示出显著相关性。液体状态变化的候选方法的检测限W(lim)评估为W(lim)=0.87 kg±0.64 kg(BIS)、1.74 kg±1.56 kg(VCD)、2.3 kg±1.0 kg(ΔRBV -)、7.4 kg±8.5 kg(CI)、40 kg±108 kg(ΔRBV +)。只有BIS显示出令人满意的低检测限W(lim),而VCD和ΔRBV - 方法的W(lim)被评为临界,CI和ΔRBV + 方法的W(lim)被评为不可接受。生物电阻抗光谱法似乎是透析中实用液体管理系统最有前景的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验